Form D · Private Equity Fund

Ambix Life Science Fund I, L.P.

Mountain View, CA · CIK 0001802535

Offering snapshot reported Apr 29, 2020 · SEC filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 29, 2020	Initial	Yet to sell	No comparison	0	SEC filing

Source: Form D, filed Apr 29, 2020. Minimum accepted may differ from a standard advertised minimum.

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

Reported in Form ADV on Mar 27, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Auditor SPICER JEFFRIES LLP DENVER, Colorado, United States

Custodian JP MORGAN CHASE MENLO PARK, California, United States Related to adviser: No

Provider details

SPICER JEFFRIES LLP
PCAOB 349

Filing source

Form ADV 2085854 · Mar 27, 2026 · Schedule D 7.B.(1), fund 805-2598821471

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
A Delaware Limited Liability Company Ambix Venture Management, Llc	Executive
Peter N Townshend	Executive

Industry: Pooled Investment Fund (See others in industry)

Address:

627 National Avenue
Mountain View, CA, 94043